Improvement by nefiracetam of /?-amyloid-(l-42)-induced learning and memory impairments in rats

British Journal of Pharmacology

Volumn 126, Issue 1, 1999, Pages 235-244

  Yamada, Kiyofumi ^a,b   Tanaka, Tomoko ^a   Mamiya, Takayoshi ^a   Shiotani, Tadashi ^a,b   Kameyama, Tsutomu ^b   Nabeshima, Toshitaka ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Alzheimer1 s disease; Amyloid ? peptide; Nefiracetam (dm 9384); Reference memory; Voltage sensitive calcium channels; Working memory

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; DOPAMINE; NEFIRACETAM; NOOTROPIC AGENT;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; HIPPOCAMPUS; LEARNING DISORDER; MALE; MAZE TEST; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; WORKING MEMORY;

3,4-DIHYDROXYPHENYLACETIC ACID; AMYLOID BETA-PROTEIN; ANIMALS; AVOIDANCE LEARNING; BIOGENIC MONOAMINES; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; DOPAMINE; FRONTAL LOBE; HIPPOCAMPUS; HOMOVANILLIC ACID; LEARNING; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY DISORDERS; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; PSYCHOTROPIC DRUGS; PYRROLIDINONES; RATS; RATS, WISTAR;

EID: 0032918505     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702309     Document Type: Article

References (57)

1. ABE, K. & KIMURA, H. (1996). Amyloid toxicity consists of a Ca2 + -independent early phase and a Ca -dependent late phase. J. Neiirochem., 67, 2074-2078.
2. ABE, E., MURAI, S., SAITO, H., MASUDA, Y. & ITOU, T. (1992). Effects of nefiracetam, a novel pyrrolidone derivative, on brain monoamine metabolisms in mice. J. Neural. Transm., 90, 125-136.
3. ABE, E., MURAI, S., SAITO, H., MASUDA, Y. & ITOH, T. (1994). Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice. J. Neural. Transm., 95, 179-193.
4. AULD, D.S., KAR, S. & QUIRION, R. (1998). -Amyloid peptides as direct cholinergic neuromodulators: a missing link? Trends Neurosci.. 21, 43-49.
5. CLEMENS, J.A. & STEPHENSON, D.T. (1992). Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol. Aging, 13, 581-586.
6. FLOOD, J.F., MORLEY, J.E. & ROBERTS, E. (1994). An amyloid -protein fragment, A/î[12-28] equipotently impairs post-training memory processing when injected into different limbic structures. Brain Res., 663, 271-276.
7. FRASER, S.P., SUY, Y.-H. & DJAMGOS M.B.A. (1997). Ionic effects of Alzheimer1 s disease /J-amyloid precursor protein and its metabolic fragments. Trends Neurosci., 20, 67-72.
8. FRICK, K., BAXTER, M.G., MARKOWSKA, A.L., OLTON, D.S. & PRICE, D.L. (1995). Age-related spatial reference and working memory deficits assessed in the water maze. Neurobiol. Aging, 16, 149-160.
9. FUJI, K., HIRAMATSU, M., KAMEYAMA, T. & NABESHIMA, T. (1993). Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. Eur. J. Pharmacol., 236, 411 -417.
10. GAMES, D., ADAMS, D., ALESSANDRINI, R., BARBOUR, R., BERTHELETTE, P., BLACKWELL, C., CARR, T., CLEMENS, I., DONALDSON, T., GILLESPIE, F., GUIDO, T., HAGOPIAN, S., JOHNSON-WOOD, K., KHAN, K., LEE, M., LEIBOWITZ, P., LIEBERBURG, L, LITTLE, S., MASLIAH, E., MCCONLOGUE, L., MONTOYA-ZAVALA, M., MUCKE, L., PAGANINI, L., PENNIMAN, E., POWER, M., SCHENK, D., SEUBERT, P., SNYDER, B., SORIANO, F., TAN, H., VITALE, J., WADSWORTH, S., WOLOZIN, B. & ZHAO, J. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F/3-amyloid precursor protein. Nature, 373, 523-527.
11. GAMES, D., KHAN, K.M., SORIANO, F.G., KEIM, P.S., DAVIS, D.L., BRYANT, K., LIEBERBURG, I. (1992). Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain. Neurobiol. Aging, 13, 569-576.
12. GIOVANNELLI, L., CASAMENTI, F., SCALI, C., BARTOLINI, L. & PEPEU, G. ( 1995). Differential effects of amyloid peptides /?-( 1 -40) and /5-(25-35) injections into the rat nucleus basalis. Neuroscience, 66, 781-792.
13. 24)25-35 in rat nucleus basalis induces behavioural dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav. Brain Res., 90, 133- 145.
14. HIRAMATSU, M., KOIDE, T., ISHIHARA, S., SHIOTANI, T., KAMEYAMA, T. & NABESHIMA, T. (1992). Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia. Enr. J. Pharmacol., 216, 279-285.
15. HOSHI, M., TAKASHIMA, A., NOGUCHI, K., MURAYAMA, M., SATO, M., KONDO, S., SAITO, Y., ISHIGURO, K., HOSHINO, T. & IMAHORI, K. (1996). Regulation of mitochondria! pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3/? in brain. Proc. Nail. Acad. Sei. U.S.A., 93,2719-2723.
16. HUANG, C.S., MA, J.Y., MARSZALEC, W. & NARAHASHI, T. (1996). Effects of the nootropic drug nefiracetam on the GABAA receptor-channel complex in dorsal root ganglion neurons. Neiiropharmacology, 35, 1251-1261.
17. ITOH, A., N1TTA, A., NADAI, M., NISHIMURA, K., HIROSE, M., HASEGAWA, T. & NABESHIMA, T. (1996). Dysfunction of cholinergic and dopaminergic neuronal systems in -amyloid protein-infused rats. J. Nciiroclicin., 66, 1113- 1117.
18. IWATSUBO, T., ODAKA, A., SUZUKI, N., MIZUSAWA, H., NUKINA, N. & IHARA, Y. (1994). Visualization of A/i42(43) and A/i40 in senile plaques with end-specific A monoclonals: evidence that an initially deposited species is A/?42(43). Neuron, 13, 45-53.
19. JARRETT, J.T. & LANSBURY, JR, P.T. (1993). Seedling 1 onedimensional crystallization1 of amyloid: a pathogenic mechanism in Alzheimer1 s disease and scrapie? Cell, 73, 1055-1058.
20. JOHNSON-WOOD, K., LEE, M., MOTTER, R., HU, K., GORDON, G., BARBOUR, R., KHAN, K., GORDON, M., TAN, 11., GAMES, D., LIEBERBURG, I., SCHENK, D., SEUBERT, P. & MCCONLOGUE, L. (1997). Amyloid precursor protein processing and Aftj deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sei. U.S.A.. 94, 1550- 1555.
21. KANEDA, N. & NAGATSU, T. (1985). Highly sensitive assay for choline acetyltransferase activity by high-performance liquid chromatography with electromechanical detection. J. Chromatogr., 341,23-30.
22. KANG, J., LEMAIRE, U.C., UNTERBECK, A., SALBAUM, J.M., MASTERS, C.L., GRZESCHIK, K.H., MULTHAUP, G., BEYREUTHER, K. & MULLER-HILL, B. (1987). The precursor of Alzheimer1 s disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733-736.
23. KAWAJIRI, S., TANIGUCHI, K., SAKURAI, T. & YAMAZAKI, T. (1994). Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat. J. Neural. Transm.,98, 15-22.
24. KOH, J.-Y., YANG, L.L. & COTMAN, C.W. (1990). /?-amy!oid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res., 533, 315-320.
25. KOWALL, W.N., BEAL, P.M., BUSCIGLIO, J., DUFFY, K.L. & YANKNER, B.A. (1991). An in vivo model for the neurodegenerative effects of /J-amyloid and protection by substance P. Proc. Natl. Acad. Sei. U.S.A., 88, 7247-7251.
26. MATTSON, M.P., CHENG, B., DAVIS, D., BRYANT, K., LIEBERBURG, I. & RYDEL, R.E. (1992). /î-amyloid pcptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci., 12, 376-389.
27. MAURICE, T., HIRAMATSU, M., ITOH, J., KAMEYAMA, T., HASEGAWA, T. & NABESHIMA, T. (1994). Behavioural evidence for a modulating role of a ligands in memory process. I. Attenuation of dizocilpine (MK.-801)-induced amnesia. Brain Res., 647, 44 56.
28. MAURICE, T., LOCKHART. B.P. & PRIVAT, A (1996). Amnesia induced by centrally administered -amyloid peptides involves cholinergic dysfunction. Brain Res., 706, 181 - 193.
29. MORRIS, R.G.M. (1984). Developments of water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods, 11,4760.
30. NABESHIMA, T. (1994). Ameliorating effects of nefiracetam (DM9384) on brain dysfunction. Drugs Today, 30, 357-379.
31. NABESHIMA, T. & ITOH, A. (1997). Toxicity of /î-amyloid protein: neurochemical, histological and behavioural changes. In: Alzlieinier1 s Disease: Biology, Diagnosis and Therapeutics, eds Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM, pp 623630. England: John Wiley & Sons Ltd.
32. NABESHIMA, T., NAKAYAMA, S., ICHIHARA, K., YAMADA, K., SHIOTANI, T. & HASEGAWA, T. (1994). Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task. Eur. J. Pharmacol., 255: 57-65.
33. NABESHIMA, T. & N1TTA, A. (1994). Memory impairment and neuronal dysfunction induced by /î-amyloid protein in rats. Tohoku J. Exp. Med., 174, 241 -249.
34. NABESHIMA, T., NODA, Y., TOHYAMA, K., ITOH, J. & KAMEYAMA, T. (1990). Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunctions. Eur. J. Pharmacol.. 178, 143-149.
35. NABESHIMA, T., OGAWA, S., KAMEYAMA, T., SHIOTANI, T., TAKASU, Y., SAKURAI, T., HASEGAWA, M. & HASEGAWA, T. (1991a). Effects of DM-9384 and aniracetam on learning in normal and basal forebrain-lesioned rats. Res. Commun. Client. Pathol. Pharmacol., 74, 141-152.
36. NABESHIMA, T., TOHYAMA, K-, MURASE, K., ISHIHARA, S., KAMEYAMA, T., YAMASAKI, T., HATANAKA, S., KOJIMA, H., SAKURAI, T., TAKASU, Y. & SHIOTANI, T. (1991b). Effects of DM-9384, a cyclic derivative of GABA, on amnesia and decrease in GABAA and muscarinic receptors induced by cycloheximide. J. Pliarnmcol. E.p. Tlier., 257, 271-275.
37. NISHIZAKI, T., MATSUOKA, T., NOMURA, T., SUMIKAWA, K., SHIOTANI, T., WATABE, S. & YOSHII, M. (1998). Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways. Mot. Pharmacol., 53, 1 -5.
38. NITTA, A., FUKUTA, T., HASEGAWA, T. & NABESHIMA, T. (1997). Continuous infusion of/î-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol., 73, 51-57.
39. NITTA, A., ITOH, A., HASEGAWA, T. & NABESHIMA, T. (1994). /?Amyloid protein-induced Alzheimer1 s disease animal model. Neitrosci. Lett., 170, 63-66.
40. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in the Stereotaxic Coordinates. New York: Academic Press.
41. SAKURAI, T., KATO, T., MORI, K., TAKANO, E., WATABE, S. & NABESHIMA, T. (1998). Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral dysfunctions: an in vivo microdialysis study. Neurosci. Lett., 246, 69-72.
42. SHINODA, I., FURUKAWA, Y. & FURUKAWA, S. (1990). Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol., 49, 18131816.
43. SHIOTANI, T., TOHYAMA, K., MURASE, K., ISHIHARA, S., KAMEYAMA, T., YAMASAKI, T., HATANAKA, S., KOJIMA, H., TAKASU, Y. & NABESHIMA, T. (1992). Effects of nefiracetam, DM-9384, on amnesia and decrease in cholineacetyltransferase activity induced by cycloheximide. J. Neural. Transm., 90, 103111.
44. STURCHLER-PIERRAT, C, ABRAMOWSKI, D., DUKE, M., WIEDERHOLD, K.-H., MISTL, C., ROTHACHER, S., LEDERMANN, B., BÜRKI, K., FREY, P., PAGANETTI, P.A., WARIDEL, C., CALHOUN, M., JUCKER, M., PROBST, A., STAUFENBIEL, M. & SOMMER, B. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acacl. Sei. U.S.A.. 94, 13287-13292.
45. TANAKA, S., WATABE, S., KAKIHATA, K., SAKURAI, T., ENDO, W., YAMAGUCHI, H. & ASIIIDA, S. (1992). Effects of the new cognition-enhancing agent nefiracetam in rats with cerebral embolism. Arzneim-Forsch/Drug Res., 42, 1274-1278.
46. TANAKA, T., YAMADA, K., SENZAKI, K., NARIMATSU, H., NISHIMURA, K., KAMEYAMA, T. & NABESHIMA, T. (1998). NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by /î-amyloid protein in rats. Eur. J. Pharmacol., 352, 135-142.
47. WATABE, S., YAMAGUCHI, H. & ASHIDA, S. (1993). DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex. Eur. J. Pharmacol., 238, 303-309.
48. WEISS, J.H., PIKE, C.J. & COTMAN, C.W. (1994). Ca2+ channel blockers attenuate -amyloid peptide toxicity to cortical neurons in culture. J. Neurochem., 62, 372-375.
49. WINKLER, J., CONGER, D.J., FRAUTSCHY, S.A., BEHL, C., WAITE, J.J., COLE, G.M. & THAL, L.J. (1994). Lack of long-term effects after /î-amyloid protein injections in rat brain. Neurobiol. Aging, 15,601-607.
50. YAMADA, K. & NABESHIMA, T. (1996). Nefiracetam (DM-9384): a novel antiamnesic drug. CNS Drug Rev., 2, 322-342.
51. YAMADA, K., NAKAYAMA, S., SHIOTANI, T., HASEGAWA, T. & NABESHIMA, T. (1994). Possible involvement of the activation of voltage-sensitive calcium channels in the ameliorating effects of nefiracetam on scopolamine-induced impairment of performance in a passive avoidance task. J. Pharmacol. Exp. Ther., 270, 881 892.
52. YAMADA, K.., NITTA, A., SAITO, T., HU, J. & NABESHIMA, T. (1995a). Changes in ciliary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid (1-40) protein. Neurosci. Lett., 201, 155-158.
53. YAMADA, K., NODA, Y., NAKAYAMA, S., KOMORI, Y., SUGIHARA, H., HASEGAWA, T. & NABESHIMA, T. (1995b). Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol., 115, 852-858.
54. YAMADA, K., NODA, Y., HASEGAWA, T., KOMORI, Y., NIKAI, T., SUGIHARA, H. & NABESHIMA,T. (1996). The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behaviour in mice. J. Pharmacol. Exp. Ther., 276, 460 -466.
55. YAMADA, K., TANAKA, T., SENZAKI, K., KAMEYAMA, T. & NABESHIMA, T. (1998). Propentofylline improves learning and memory deficits in rats induced by /î-amyloid protein-(l-40). Eur. J. Plmrinacol.,349, 15-22.
56. YANKNER, B.A., DUFFY, L.K. & KIRSCHNER, D.A. (1990). Neurotrophic and neurotoxic effects of amyloid protein: reversla by tachykinin neuropeptides. Science, 250, 279-282.
57. YOSHII, M. & WATABE, S. (1994). Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Brain Res.. 642, 123-131.